Insights On Quality Control

  1. Quantitative Determination Of Amorphous And Crystalline Drug In Polymer Microspheres 12/30/2024

    Biodegradable polymer microspheres control drug release through crystalline and amorphous properties, analyzed using DSC, MDSC, and TGA to determine composition and stability for precise delivery.

  2. Human Performance In Pharma: Strengthening The Biotech Workforce 11/24/2025

    Transforming the pharma workforce requires strategic partnerships and a shift toward behavioral and operational readiness, moving beyond simple technical training to ensure performance and compliance.

  3. Effective Staffing Plans For GMP Drug Manufacturing Facilities 8/12/2024

    In the manufacturing industry, the proper planning and staffing of GMP facilities and production lines are crucial for efficient operations and successful outcomes.

  4. Building Control Strategies: It's Time To Go Digital 1/24/2025

    Digital control strategies in pharma enhance product quality, regulatory compliance, and efficiency by leveraging real-time monitoring, automated documentation, and Quality by Design (QbD) frameworks.

  5. Improving Bioprocess Monitoring And Control With Multivariate Data Analysis 12/9/2024

    Learn about multivariate data analysis (MVDA) techniques, like PCA and PLS, that enable near real-time monitoring, prediction, and optimization of biomanufacturing processes.

  6. EMPQ And Validation Support Services 2/21/2024

    A growing pharmaceutical/biotech company hired a global consulting firm for a project that required EMPQ services for qualification activities on a newly completed aseptic processing suite.

  7. Digitizing Quality Management: The Key To Avoiding FDA Recalls In Life Sciences 1/13/2025

    Explore the need for digital quality management systems to ensure compliance as life science companies face rising FDA recalls.

  8. Essential Insights Into Pharmaceutical Product Release, Part 1 Of 2 12/27/2024

    Pharma product release ensures drug quality, safety, and regulatory compliance by evaluating manufacturing and quality processes. It’s a critical, comprehensive process essential for FDA approval and patient safety.

  9. Water Activity And Primary Packaging For Oral Solid Dose Products 7/10/2024

    The draft of the general chapter USP<922> says water activity determination can be used to assess the level of protection of primary packaging for an oral solid dosage product over its entire shelf life.

  10. The Seamless Path To Market: End-To-End CDMOs As Your Strategic Ally Douglas CDMO 5/14/2025

    Partner with an experienced end-to-end CDMO to streamline development, reduce risk, and accelerate your drug’s path to market in today’s complex and competitive pharmaceutical landscape.